merged_variant-bio-novo-nordisk-indigenous-revenue-sharing.txt
<question_number>1</question_number>
<answer>N/A</answer>
<question_number>2</question_number>
<answer>$100,000</answer>
<question_number>3</question_number>
<answer>8</answer>
<question_number>4</question_number>
<answer>N/A</answer>
<question_number>5</question_number>
<answer>Lux Capital</answer>
<question_number>6</question_number>
<answer>Nagoya Protocol</answer>
<question_number>7</question_number>
<answer>gout</answer>
<question_number>8</question_number>
<answer>Krystal Tsosie</answer>
<question_number>9</question_number>
<answer>graduate researchers in genetics</answer>
<question_number>10</question_number>
<answer>N/A</answer>
<question_number>11</question_number>
<answer>4%</answer>
<question_number>12</question_number>
<answer>Karitiana tribe</answer>
<question_number>13</question_number>
<answer>Stephane Castel</answer>
<question_number>14</question_number>
<answer>10%</answer>
<question_number>15</question_number>
<answer>Lux Capital</answer>
<question_number>16</question_number>
<answer>Keolu Fox</answer>
<question_number>17</question_number>
<answer>DNA samples were collected and later sold for $85 per sample without benefit-sharing</answer>
<question_number>18</question_number>
<answer>Inuit</answer>
<question_number>19</question_number>
<answer>Nagoya Protocol</answer>
<question_number>20</question_number>
<answer>drugs developed from the partnership</answer>